Pharmala Biotech Holdings (XCNQ:MDMA) Inventories, Work In Process : C$0.00 Mil (As of Feb. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Pharmala Biotech Holdings Inventories, Work In Process?

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Pharmala Biotech Holdings's work in process for the quarter that ended in Feb. 2024 was C$0.00 Mil.

Pharmala Biotech Holdings Inventories, Work In Process Historical Data

The historical data trend for Pharmala Biotech Holdings's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmala Biotech Holdings Inventories, Work In Process Chart

Pharmala Biotech Holdings Annual Data

Trend

Aug21

Aug22

Aug23

Inventories, Work In Process

Pharmala Biotech Holdings Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Inventories, Work In Process	Get a 7-Day Free Trial							-	-	-	-	-

Pharmala Biotech Holdings Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

Pharmala Biotech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmala Biotech Holdings Inc (XCNQ:MDMA) » Definitions » Inventories, Work In Process

Comparable Companies

Traded in Other Exchanges

MDXXF:USA

Address

82 Richmond Street East, Toranto, ON, CAN, M5C 1P1

Website

https://www.pharmala.ca

Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. PharmAla's drug API is manufactured and encapsulated under GMP conditions. The Company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations.

Executives

Perry Tsergas	Director
Shane H.d. Morris	Director, Senior Officer
Nicholas Kadysh	Director, Senior Officer
Fraser Macdonald	Director

Pharmala Biotech Holdings Headlines

No Headlines